Marie-Aude Lefrère-Belda
Paris Descartes University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Marie-Aude Lefrère-Belda.
European Journal of Endocrinology | 2009
Anne Bachelot; A. Rouxel; Nathalie Massin; Jérôme Dulon; Carine Courtillot; Christine Matuchansky; Yasmina Badachi; Anne Fortin; B. Paniel; Fabrice Lecuru; Marie-Aude Lefrère-Belda; Elisabeth Constancis; Elisabeth Thibault; Geri Meduri; Anne Guiochon-Mantel; Micheline Misrahi; Frédérique Kuttenn; Philippe Touraine
OBJECTIVE Premature ovarian failure (POF) encompasses a heterogeneous spectrum of conditions, with phenotypic variability among patients. The etiology of POF remains unknown in most cases. We performed a global phenotyping of POF women with the aim of better orienting attempts at an etiological diagnosis. DESIGN AND METHODS We performed a mixed retrospective and prospective study of clinical, biological, histological, morphological, and genetic data relating to 357 consecutive POF patients between 1997 and 2008. The study was conducted at a reproductive endocrinology referral center. RESULTS Seventy-six percent of the patients presented with normal puberty and secondary amenorrhea. Family history was present in 14% of the patients, clinical and/or biological autoimmunity in 14.3%. Fifty-six women had a fluctuating form of POF. The presence of follicles was suggested at ultrasonography in 50% of the patients, and observed in 29% at histology; the negative predictive value of the presence of follicles at ultrasonography was 77%. Bone mineral density alterations were found in 58% of the women. Eight patients had X chromosomal abnormalities other than Turners syndrome, eight other patients evidenced FMR1 pre-mutation. Two other patients had autoimmune polyendocrine syndrome type 2 and 1. CONCLUSION A genetic cause of POF was identified in 25 patients, i.e. 7% of the whole cohort. POF etiology remains most often undiscovered. Novel strategies of POF phenotyping are in such content mandatory to improve the rate of POF patients for whom etiology is identified.
Journal of Obstetrics and Gynaecology Research | 2012
Cyrille Huchon; Ulrike Metzger; Anne-Sophie Bats; C. Bensaid; Gilles Chatellier; Michel Azizi; Marie-Aude Lefrère-Belda; Arnaud Dujardin; J. Bernard; F. Lecuru
Aims: The aim of this study was to assess the diagnostic performance of 3‐D contrast‐enhanced power Doppler ultrasonography (3‐D CEPDUS) for differentiating benign and malignant adnexal masses.
Gynecologic and Obstetric Investigation | 2004
Ulrike Metzger; J. P. Bernard; Sophie Camatte; Loic Lelievre; François Robin; Marie-Aude Lefrère-Belda; Fabrice Lecuru
Objective: To assess the feasibility, tolerance and diagnostic accuracy of endometrial biopsy (EB) during sonohysterography (SH) compared to EB after hysteroscopy (HSC) in endometrial disorders. Methods: 105 consecutive patients with irregular uterine bleeding were included prospectively in the calendar year 2001. SH and flexible HSC were performed in an office setting, subsequently and in a random order, by two different practitioners blind to the former experiment. SH-EB was performed using a 3.1-mm ultrasound-guided Bernard catheter in the uterine cavity still partly distended and with a gentle 20-ml syringe vacuum aspiration. The biopsy was directed on focal lesions or else randomly when no targets had previously been found. A Cornier Pipelle® was used to perform EB after HSC. We investigated all patients by biopsy, independent of the endometrial thickness. HSC-EB was the gold standard. Results: For both methods, cervical catheterism was impossible in 20 patients, 75 of them successfully underwent both exams. Duration and tolerance were similar. SH was effective in the distinction between normal and pathologic cavities, as well as in the diagnosis of polyps. Endometrium appeared significantly thinner with HSC (1.8 mm) when compared to SH (2.9 mm, p < 0.05). Histological endometrial assessment failed in 30 cases of SH-EB and in 22 cases in HSC-EB (NS). There was a poor correlation of the histological results of both techniques. Hyperplasia has never been diagnosed by SH-EB, whereas 3 EB issued from HSC-EB brought up this diagnosis. Conclusion: SH-EB with our technique did not improve the diagnostic potential of SH and severe diagnosis was missed. Histological assessment should fail less when we exclude endometrial atrophy. The diameter of the catheter and the aspiration technique must be revised and the learning curve must be considered. Our technique cannot replace EB by HSC.
Cancer Immunology, Immunotherapy | 2011
S. Oudard; Olivier Rixe; Benoit Beuselinck; Claude Linassier; Eugeniu Banu; Jean-Pascal Machiels; Marion Baudard; François Ringeisen; Thierry Velu; Marie-Aude Lefrère-Belda; Jean-Marc Limacher; Wolf H. Fridman; Michel Azizi; Bruce Acres; Eric Tartour
Gynecologic Oncology | 2007
Anne-Sophie Bats; Denys Clément; Florence Larousserie; Marie-Aude Lefrère-Belda; Marc Faraggi; Marc Froissart; F. Lecuru
Investigational New Drugs | 2015
Pierre Combe; Laure Chauvenet; Marie-Aude Lefrère-Belda; Hélène Blons; Caroline Rousseau; S. Oudard; Eric Pujade-Lauraine
Bulletin Du Cancer | 2007
Anne-Sophie Bats; Gilles Chatellier; Denys Clément; Florence Larousserie; Marie-Aude Lefrère-Belda; Fabrice Lecuru; Claude Nos
La Revue du praticien | 2004
Fabrice Lecuru; Ulrike Metzger; Eric Levy; Marie-Aude Lefrère-Belda; C. Bensaid
Ultrasound in Medicine and Biology | 2016
Foucauld Chamming's; Marie-Aude Lefrère-Belda; Heldmuth Latorre-Ossa; Victor Fitoussi; Alban Redheuil; Franck Assayag; Laetitia Pidial; Jean-Luc Gennisson; Mickael Tanter; C.A. Cuenod; L. Fournier
Gynecologie Obstetrique & Fertilite | 2011
Khadija Fathallah; Cyrille Huchon; Anne Sophie Bats; Ulrike Metzger; Marie-Aude Lefrère-Belda; C. Bensaid; Fabrice Lecuru